Dr. Saha is a medical oncologist who treats patients with liver cancer.
I believe strongly in patient-centered care. As a medical oncologist, my goal is to help patients and their families understand their diagnosis and potential treatments, including standard options and clinical trials.
Liver cancers, including hepatocellular carcinoma and cholangiocarcinoma
- Assistant Professor, UW School of Medicine
- Assistant Member, Fred Hutchinson Cancer Research Center
- Bachelor's degree: Harvard University
- MD: UCLA School of Medicine
- PhD: UCLA School of Medicine
- Residency: Brigham and Women's Hospital
- Fellowship: Dana-Farber Cancer Institute
Learn more about Dr. Saha's research: Saha Laboratory for Liver Cancer Translational Research
When Supriya Saha, MD, PhD, was in high school, he helped his mother set up a psychiatry clinic in a small town in South Carolina. He was able to see firsthand how a physician can help patients overcome truly debilitating diseases and re-enter society.
"Although I was always strongly attracted to science and research, this experience made me realize that it was also important for me to have the opportunity to directly improve the lives of patients as a physician," he says.
Dr. Saha decided to pursue medical oncology after caring for his first cancer patient as a medical student at UCLA. "The experience brought a profound sense of purpose and perspective to each day I cared for her. I hoped our interactions would help her come to terms with her condition, find hope, and prepare for her future treatment."
In addition to caring for patients, Dr. Saha is involved in liver cancer research. His laboratory studies the second most common form of liver cancer called cholangiocarcinoma, which has been increasing in incidence in the United States and world-wide for almost 40 years.
"We use a variety of tools, including cell lines and mouse models, to try to understand how this disease initially starts and identify new therapies to target specific mutations or pathways in the tumor," Dr. Saha says.
For the future, Dr. Saha hopes that comprehensive molecular profiling of every patient’s tumor will become routine and affordable, allowing doctors to tailor therapies toward each patient's specific molecular profile. "In the long run, I hope we will learn how to harness our body’s immune system to eradicate these tumors completely," he adds.
Outside of work, Dr. Saha enjoys spending time with his wife and son, playing tennis, hiking and running.